Glimepiride Tablets top

Glimepiride 1mg tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets (Dibei), as the first hypoglycemic product of Beilu Pharma, was first listed in China and belongs to the second class of national new drugs.

 

Product name: Glimepiride Tablets

Specifications: glimepiride tab 1mg×30 tabletsglimepiride 2 mg×15 tabletsglimepiride 2mg×30 tablets

 

Characteristics: White tablet

 

Indications :

As one of the oral antidiabetic drugs produced by Beilu Pharma, our glimepiride tablets are only suitable for type 2 diabetes that cannot fully control blood sugar through diet control, exercise therapy and weight loss.

 

glimepiride 2 tablet are not suitable for type 1 diabetes (for example, the treatment of diabetic patients with a history of ketoacidosis), diabetic ketoacidosis or Treatment of pre-diabetic coma or coma.

 

Usage and Dosage: Please refer to the glimepiride package insert

Adverse reactions, Contraindications, Precautions: Please refer to the package insert.

Storage: Shade, seal, and keep in a dry place.

Packaging: Aluminum plastic packaging, 15 pills/plate, 1 plate/box; 15 pills/plate, 2 plates/box.

Shelf life: 24 months

 

Advantages of Glimepiride Tablets

Double effect directly hit the hypoglycemic core

 

Double effect: Glimepiride tablets can promote insulin secretion and improve insulin resistance. At the same time, it can improve the two major pathophysiological abnormalities of insulin secretion and insulin resistance in patients with type 2 diabetes.

 

Efficiently reduce postprandial blood glucose, fasting blood glucose and glycosylated haemoglobin

 

Glimepiride tablets monotherapy can comprehensively reduce FPG PPG and HbA1c in newly diagnosed T2DM patients

 

Combination therapy, such as combined metformin, acarbose, etc., has a more significant overall hypoglycemic effect

 

Less hypoglycemia, less weight impact, high safety

Short-term treatment, the risk of glimepiride hypoglycemia is only 1/3 of that of Glibenclamide

Long-term treatment, the risk of glimepiride hypoglycemia is only 1/7of that of Glibenclamide

Glimepiride has a small impact on the weight of T2DM patients

 

Once a day to improve patient compliance

If the patient's compliance is poor, Glimepiride tablets should be selected, once a day.

 

For more information about glimepiride 2mg tablets used for and side effects of glimepiride 1mg tablet, please feel free to contact us!

 

As a professional contrast media manufacturer, Beilu has high-quality ct contrast media for sale. Welcome to contact us if needed.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Founded in 1992, Beilu is a high-tech innovation company with core competence in diagnostic imaging field in China.We have the most complete Contrast media categories and are the leading manufacture in Contrast media field in China. It is one of the 1st batch of listed enterprises in GEM in China. Beilu s main products are Contrast media, psychoneurosis traditional Chinese medicine and endocrinology drugs that to benefit people and improve their quality of life.https://www.beilupharma.com/